InVivo Therapeutics Holdings Corp. (NVIV) today announced that
Mark Perrin, InVivo’s Chief Executive Officer, is scheduled to present
to investors at the 16th Annual Rodman & Renshaw Healthcare
Conference to be held September 8-10, 2014 at the New York Palace Hotel
in New York City. The presentation is scheduled for Wednesday, September
10th at 9:10AM ET. A live webcast will be available at http://wsw.com/webcast/rrshq24/nviv.
Additional information about the conference can be found at http://www.rodm.com/
InVivo will also be participating in the First Annual Zacks Healthcare
Meetup on Monday, September 8th.
Mark Perrin said, “These meetings represent great opportunities for
InVivo to update loyal investors and attract new investors alike. Both
meetings are important components of a concerted effort to increase
interaction with the investment community. I am excited to tell the
story of the new InVivo and our efforts to develop effective therapies
for spinal cord injury.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and
biotechnology company with a focus on treatment of spinal cord injuries.
The company was founded in 2005 with proprietary technology co-invented
by Robert Langer, ScD., Professor at Massachusetts Institute of
Technology, and Joseph P. Vacanti, M.D., who is affiliated with
Massachusetts General Hospital. In 2011 the Company earned the David S.
Apple Award from the American Spinal Injury Association for its
outstanding contribution to spinal cord injury medicine. The publicly
traded company is headquartered in Cambridge, MA. For more details,
visit, www.invivotherapeutics.com.
Copyright Business Wire 2014